EYE Strategy Career Opportunities



Work with us! 

We have another career opportunity on the EYE Secretariat.

Consultant – Epidemiologist (yellow fever)

Deadline for applications is 30th November 2022, 22:59 Central European Time. For more information and to apply, click here.


To respond to the increased risk of large urban yellow fever outbreaks with international spread that could threaten global health security, the comprehensive, multicomponent Global Eliminate Yellow Fever Epidemics (EYE) strategy was developed by EYE partners.

To ensure and guide successful implementation, 3 strategic objectives were defined together with milestones to be attained throughout a 10-year timeline (2017-2026).

The EYE Strategy endorses a continuum of preventive activities, ranging from preventive vaccination activities with implementation tiered according to risk, to rapid detection and response to outbreaks.

The global health community is facing an increased risk of urban yellow fever outbreaks as a re-emerging threat to global health security. The epidemiology of yellow fever epidemics has recently shifted, with resurgence of the disease in parts of the world not deemed to be at highest risk, such as the 2016 outbreaks in Angola and DRC, the 2018 and 2020 yellow fever outbreaks in Ethiopia, the 2002 outbreaks in multiple countries in Africa and the 2017-19 outbreaks in Brazil’s coastal areas.

Some of the evolving epidemiology is related to issues with sub-optimal routine immunization coverages in high-risk countries, which have completed nationwide preventive campaigns, resulting in growing accumulation of susceptible populations.

This was the cause of the resurgence of yellow fever in late 2020 in some West African countries, such as Guinea and Senegal. In addition to causing morbidity and mortality locally, the resurgence of yellow fever in countries in Africa and the Americas increases the risk of spread regionally and globally.

Key aspects of the role

Task 1: To conduct sub-national yellow fever risk assessments and develop risk profiles validated with country stakeholders in at least 3-4 countries in Africa.

Output 1: Sub-national yellow fever risk assessment and risk profiles validated with country stakeholders in at least 3-4 countries in Africa (expected by the end of contract).

Task 2: To conduct analysis work in collaboration with the Risk Analysis Working Group (RAWG).

Output 2: Two updated risk ranking of countries using standardized methodology (expected by early 2023 and mid 2023).

Task 3: To provide technical appraisal of a model developed to create vaccine coverage heat maps for countries in Africa to improve identification of critical immunity gaps.

Output 3: Written guidance on use of the model, suggestions for improvement on use of the model to identify immunity gaps (final draft expected by the end of contract).

Task 4: To plan and convene an in-country workshop, assuring MoH engagement and partner participation in relation to a subnational risk analysis for YF in a high-risk country in Africa.

Output 4: Technical guidance development for MoH on YF risk analysis (final draft expected by the end of contract).

For more information on the role and how to apply click here.

Please circulate widely within your networks.

With thanks, 

Laurence Cibrelus - Head of the EYE Strategy Secretariat

More on the EYE strategy can be found here. More information on yellow fever can be found here.


To subscribe to this newsletter, click here.
Follow us on social media. Click on the icons below.


To read the EYE Strategy, click here 
To visit the WHO yellow fever pages, click here 
To contact EYE, email This email address is being protected from spambots. You need JavaScript enabled to view it.

Copyright © 2021 World Health Organization, All rights reserved.



By accepting you will be accessing a service provided by a third-party external to https://www.technet-21.org/